| Network model of survival signaling in large granular lymphocyte leukemia R Zhang, MV Shah, J Yang, SB Nyland, X Liu, JK Yun, R Albert, ... Proceedings of the National Academy of Sciences 105 (42), 16308-16313, 2008 | 437 | 2008 |
| Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes MV Shah, R Zhang, R Irby, R Kothapalli, X Liu, T Arrington, B Frank, ... Blood, The Journal of the American Society of Hematology 112 (3), 770-781, 2008 | 138 | 2008 |
| Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease G Goyal, A Ravindran, JR Young, MV Shah, NN Bennani, MM Patnaik, ... Haematologica 105 (2), 348, 2020 | 135 | 2020 |
| The Mayo Clinic Histiocytosis Working Group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease … G Goyal, JR Young, MJ Koster, WO Tobin, R Vassallo, JH Ryu, ... Mayo Clinic Proceedings 94 (10), 2054-2071, 2019 | 102 | 2019 |
| NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human J Yu, T Mitsui, M Wei, H Mao, JP Butchar, MV Shah, J Zhang, A Mishra, ... The Journal of clinical investigation 121 (4), 1456-1470, 2011 | 98 | 2011 |
| Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients E Morsia, K McCullough, M Joshi, J Cook, HB Alkhateeb, A Al‐Kali, ... American journal of hematology 95 (12), 1511-1521, 2020 | 97 | 2020 |
| The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders R Zhang, MV Shah, TP Loughran Jr Hematological oncology 28 (3), 105-117, 2010 | 93 | 2010 |
| Acid ceramidase is upregulated in AML and represents a novel therapeutic target SF Tan, X Liu, TE Fox, BM Barth, A Sharma, SD Turner, A Awwad, ... Oncotarget 7 (50), 83208, 2016 | 82 | 2016 |
| Haploidentical transplantation for older patients with acute myeloid leukemia and myelodysplastic syndrome SO Ciurea, MV Shah, RM Saliba, S Gaballa, P Kongtim, G Rondon, ... Biology of Blood and Marrow Transplantation 24 (6), 1232-1236, 2018 | 74 | 2018 |
| Early post-transplant minimal residual disease assessment improves risk stratification in acute myeloid leukemia MV Shah, JL Jorgensen, RM Saliba, SA Wang, AM Alousi, BS Andersson, ... Biology of Blood and Marrow Transplantation 24 (7), 1514-1520, 2018 | 73 | 2018 |
| Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory … MV Shah, AE Wiktor, RG Meyer, KS Tenner, KV Ballman, SJ Green, ... Journal of Clinical Oncology 34 (29), 3502-3510, 2016 | 71 | 2016 |
| A population-based study of large granular lymphocyte leukemia MV Shah, CC Hook, TG Call, RS Go Blood Cancer Journal 6 (e455), 2016 | 70 | 2016 |
| Clinical and radiologic responses to cladribine for the treatment of Erdheim-Chester disease G Goyal, MV Shah, TG Call, MR Litzow, WJ Hogan, RS Go JAMA oncology 3 (9), 1253-1256, 2017 | 60 | 2017 |
| Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long‐term outcomes. G Goyal, MV Shah, CC Hook, AP Wolanskyj, TG Call, KL Rech, RS Go British journal of haematology 182 (4), 2018 | 59 | 2018 |
| Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia ZS Hasanali, BS Saroya, A Stuart, S Shimko, J Evans, MV Shah, ... Science translational medicine 7 (293), 293ra102-293ra102, 2015 | 58 | 2015 |
| Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia A Liao, K Broeg, T Fox, SF Tan, R Watters, MV Shah, LQ Zhang, Y Li, ... Blood, The Journal of the American Society of Hematology 118 (10), 2793-2800, 2011 | 53 | 2011 |
| Genetic and genomic landscape of secondary and therapy-related acute myeloid leukemia A Higgins, MV Shah Genes 11 (7), 749, 2020 | 42 | 2020 |
| Efficacy of biological agents in the treatment of Erdheim‐Chester disease. G Goyal, MV Shah, TG Call, MR Litzow, AP Wolanskyj‐Spinner, MJ Koster, ... British journal of haematology 183 (3), 2018 | 34 | 2018 |
| Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms HB Alkhateeb, A Nanaa, D Viswanatha, JM Foran, T Badar, L Sproat, ... Blood advances 6 (2), 528-532, 2022 | 33 | 2022 |
| Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation M Joshi, J Cook, K McCullough, A Nanaa, N Gangat, JM Foran, ... Blood cancer journal 11 (3), 49, 2021 | 30 | 2021 |
Hassan AlkhateebMayo ClinicVerified email at mayo.edu
